1. Home
  2. UFI vs ONCY Comparison

UFI vs ONCY Comparison

Compare UFI & ONCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Unifi Inc. New

UFI

Unifi Inc. New

HOLD

Current Price

$5.54

Market Cap

76.4M

ML Signal

HOLD

Logo Oncolytics Biotech Inc.

ONCY

Oncolytics Biotech Inc.

HOLD

Current Price

$0.51

Market Cap

80.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UFI
ONCY
Founded
1969
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Textiles
Pharmaceuticals and Biotechnology
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
76.4M
80.5M
IPO Year
1994
2002

Fundamental Metrics

Financial Performance
Metric
UFI
ONCY
Price
$5.54
$0.51
Analyst Decision
Buy
Analyst Count
0
6
Target Price
N/A
★ $4.16
AVG Volume (30 Days)
60.1K
★ 1.4M
Earning Date
11-03-2026
11-11-2026
Dividend Yield
★ 30.77%
N/A
EPS Growth
N/A
★ N/A
EPS
N/A
★ N/A
Revenue
★ $531,303,000.00
N/A
Revenue This Year
$4.12
N/A
Revenue Next Year
$9.69
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ N/A
52 Week Low
$2.96
$0.44
52 Week High
$8.47
$1.32

Technical Indicators

Market Signals
Indicator
UFI
ONCY
Relative Strength Index (RSI) 30.46 31.49
Support Level $3.62 $0.44
Resistance Level $6.79 $0.89
Average True Range (ATR) 0.26 0.06
MACD -0.07 -0.00
Stochastic Oscillator 9.66 32.34

Price Performance

Historical Comparison
UFI
ONCY

About UFI Unifi Inc. New

Unifi Inc is a multi-national company. It manufactures and sells synthetic and recycled products made from polyester and nylon predominantly to other yarn manufacturers and knitters and weavers that produce fabric for apparel, hosiery, home furnishings, automotive, industrial, and other end-use markets. Polyester yarns include partially oriented yarn (POY), textured, solution and package dyed, twisted, beamed, and draw wound yarns, and each is available in virgin or recycled varieties. UNIFI offers specialized yarns, premium value-added (PVA) yarns, and commodity yarns. The company's reportable segments are; the Americas, Brazil, and Asia. Its maximum revenue is derived from the Americas.

About ONCY Oncolytics Biotech Inc.

Oncolytics Biotech Inc is a clinical-stage biopharmaceutical company. The company is focused on the discovery and development of pharmaceutical products for the treatment of cancers that have not been treated with therapeutics. It is developing pelareorep, an immunotherapeutic agent that improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The other projects in the company's pipeline include Bracelet-1 for the treatment of Breast Cancer, Goblet cohort-1, and Goblet cohort-5 for the treatment of Gastro-Intestinal Cancer, among others.

Share on Social Networks: